Vir Biotechnology, Inc. VIR Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s retained earnings?
- Vir Biotechnology, Inc. (VIR) reported retained earnings of -$1.32B in Q1 2026.
- How has Vir Biotechnology, Inc.'s retained earnings changed year-over-year?
- Vir Biotechnology, Inc.'s retained earnings decreased by 50.3% year-over-year, from -$880.75M to -$1.32B.
- What is the long-term trend for Vir Biotechnology, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s retained earnings has grown at a 12.4% compound annual growth rate (CAGR), from -$667.18M to -$1.2B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.